Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahnavaz, S. A.
Right arrow Articles by Jordan, R. C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shahnavaz, S. A.
Right arrow Articles by Jordan, R. C. K.
[Cancer Research 61, 2371-2375, March 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Patterns of CDKN2A Gene Loss in Sequential Oral Epithelial Dysplasias and Carcinomas1

S. Ali Shahnavaz, Grace Bradley, Joseph A. Regezi, Nalin Thakker, Luzhang Gao, David Hogg and Richard C. K. Jordan2

Faculty of Dentistry [S. A. S., G. B.], and Faculty of Medicine [L. G., D. H.], University of Toronto, Toronto, Ontario M5G1G6, Canada; Department of Stomatology, University of California San Francisco, San Francisco, California 94143 [J. A. R., R. C. K. J.]; and University of Manchester, Manchester M13 9PL, United Kingdom [N. T.]

The CDKN2A gene locus encodes two different proteins derived from alternative splicing. p16 (exons 1{alpha}, 2, and 3) acts as a G1 cell cycle regulator, and p14ARF (exons 1ß, 2, and 3) acts to modulate MDM2-mediated degradation of p53. Inactivation of p16 is a common finding in many cancers; however, there is little data on CDKN2A gene abnormalities in oral precancer. In this longitudinal study, we examined changes in the CDKN2A gene locus in sequential epithelial dysplasias and oral carcinomas from 11 patients. Genomic DNA was extracted from laser-microdissected lesional tissue, and exons 1{alpha}, 1ß, and 2 were analyzed by duplex PCR. Immunohistochemistry was done to identify p16 and p14ARF protein expression. Two adjacent polymorphic microsatellite markers were used for allelotyping. Homozygous deletion of exon 1{alpha} was identified in 2 of 17 (12%) precancerous lesions. Loss of either exon 1{alpha}, exon 2, or both was seen in seven of nine (78%) carcinomas. In five of these carcinomas, there was loss of only exon 1{alpha}. No case showed deletion of exon 1ß. In 5 of 11 patients, microsatellite markers showed differing patterns of allelic imbalance in the precancerous lesions and the subsequent carcinoma, suggesting a complex genetic pattern of progression from dysplasia to carcinoma. We conclude that during oral carcinogenesis homozygous deletion of exon 1{alpha} of the CDKN2A gene is common but that deletion of exon 2 and 1ß is less frequent. Moreover, our results suggest that the progression from oral precancer to cancer, in some cases, is more complex genetically than predicted by linear models of carcinogenesis.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. A. Kresty, S. R. Mallery, T. J. Knobloch, J. Li, M. Lloyd, B. C. Casto, and C. M. Weghorst
Frequent Alterations of p16INK4a and p14ARF in Oral Proliferative Verrucous Leukoplakia
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3179 - 3187.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Kresty, S. R. Mallery, T. J. Knobloch, H. Song, M. Lloyd, B. C. Casto, and C. M. Weghorst
Alterations of p16INK4a and p14ARF in Patients with Severe Oral Epithelial Dysplasia
Cancer Res., September 15, 2002; 62(18): 5295 - 5300.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.